What is Protagonist Therapeutics's other working capital?

Protagonist Therapeutics (PTGX) reported other working capital of -$2K in Q1 2026.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Protagonist Therapeutics PTGX Other Working Capital

Other Working Capital at other companies

Bristol-Myers SquibbBMY

$1.64B+54.5%

Eli LillyLLY

-$175M-137%

AmgenAMGN

$67M+34.0%

IncyteINCY

-$12.77M-141%

ImmunityBio, Inc.IBRX

$16K-93.4%

Kymera TherapeuticsKYMR

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingActivitiesCashFlowStatement.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's other working capital?: Protagonist Therapeutics (PTGX) reported other working capital of -$2K in Q1 2026.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.